Mark Mikkelsen
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 40 | 2026 | 908 | 5.700 |
Why?
| | Sepsis | 37 | 2026 | 669 | 5.640 |
Why?
| | Critical Care | 24 | 2026 | 706 | 3.740 |
Why?
| | Intensive Care Units | 41 | 2026 | 925 | 3.590 |
Why?
| | Survivors | 25 | 2026 | 526 | 3.300 |
Why?
| | Patient Readmission | 13 | 2021 | 778 | 2.870 |
Why?
| | Magnetic Resonance Spectroscopy | 11 | 2022 | 627 | 2.370 |
Why?
| | Respiration, Artificial | 14 | 2026 | 711 | 2.110 |
Why?
| | gamma-Aminobutyric Acid | 8 | 2022 | 195 | 1.940 |
Why?
| | Hospital Mortality | 21 | 2021 | 1051 | 1.450 |
Why?
| | Shock, Septic | 10 | 2021 | 230 | 1.430 |
Why?
| | Patient Discharge | 9 | 2022 | 997 | 1.390 |
Why?
| | Extracorporeal Membrane Oxygenation | 8 | 2022 | 370 | 1.260 |
Why?
| | Delirium | 3 | 2023 | 107 | 1.200 |
Why?
| | Home Care Services | 7 | 2026 | 293 | 1.190 |
Why?
| | Burnout, Professional | 3 | 2022 | 493 | 1.180 |
Why?
| | Cognition Disorders | 5 | 2017 | 559 | 1.170 |
Why?
| | Brain | 10 | 2022 | 2991 | 1.040 |
Why?
| | Humans | 135 | 2026 | 146342 | 1.010 |
Why?
| | Quality of Life | 11 | 2022 | 3200 | 0.970 |
Why?
| | Hospitalization | 9 | 2023 | 2475 | 0.960 |
Why?
| | Subacute Care | 3 | 2020 | 85 | 0.870 |
Why?
| | Emergency Service, Hospital | 13 | 2020 | 2363 | 0.850 |
Why?
| | Hypothermia, Induced | 4 | 2016 | 96 | 0.850 |
Why?
| | Heart Arrest | 5 | 2016 | 411 | 0.840 |
Why?
| | Patients | 2 | 2016 | 183 | 0.800 |
Why?
| | APACHE | 8 | 2021 | 67 | 0.790 |
Why?
| | Dyspnea | 1 | 2025 | 251 | 0.760 |
Why?
| | Acute Lung Injury | 5 | 2013 | 312 | 0.750 |
Why?
| | Goals | 2 | 2021 | 187 | 0.740 |
Why?
| | Organ Dysfunction Scores | 2 | 2020 | 55 | 0.730 |
Why?
| | Academic Medical Centers | 8 | 2022 | 561 | 0.720 |
Why?
| | Peer Group | 4 | 2021 | 251 | 0.680 |
Why?
| | Social Support | 4 | 2021 | 646 | 0.680 |
Why?
| | Male | 76 | 2026 | 73396 | 0.670 |
Why?
| | Pneumonia, Viral | 3 | 2021 | 387 | 0.660 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2019 | 102 | 0.660 |
Why?
| | Retrospective Studies | 39 | 2022 | 17438 | 0.630 |
Why?
| | Glutathione | 3 | 2020 | 369 | 0.630 |
Why?
| | Female | 74 | 2026 | 79499 | 0.620 |
Why?
| | Happiness | 1 | 2020 | 21 | 0.620 |
Why?
| | Professional-Family Relations | 1 | 2021 | 158 | 0.610 |
Why?
| | Coronavirus | 1 | 2020 | 47 | 0.610 |
Why?
| | Pennsylvania | 11 | 2021 | 136 | 0.600 |
Why?
| | Middle Aged | 52 | 2021 | 36619 | 0.590 |
Why?
| | Pandemics | 5 | 2022 | 1707 | 0.580 |
Why?
| | Aftercare | 4 | 2022 | 225 | 0.570 |
Why?
| | Terminal Care | 2 | 2020 | 284 | 0.560 |
Why?
| | Aged | 41 | 2021 | 26432 | 0.550 |
Why?
| | Status Asthmaticus | 2 | 2009 | 13 | 0.550 |
Why?
| | Coronavirus Infections | 2 | 2020 | 379 | 0.550 |
Why?
| | Hospitals, Community | 2 | 2026 | 68 | 0.530 |
Why?
| | Algorithms | 3 | 2022 | 1849 | 0.530 |
Why?
| | Life Support Care | 2 | 2009 | 44 | 0.530 |
Why?
| | Health Plan Implementation | 2 | 2016 | 143 | 0.530 |
Why?
| | Cognitive Dysfunction | 3 | 2020 | 481 | 0.520 |
Why?
| | Patient Participation | 1 | 2021 | 457 | 0.510 |
Why?
| | Family | 2 | 2021 | 690 | 0.510 |
Why?
| | Job Satisfaction | 1 | 2019 | 236 | 0.500 |
Why?
| | Early Diagnosis | 4 | 2015 | 251 | 0.500 |
Why?
| | Lactic Acid | 7 | 2020 | 295 | 0.490 |
Why?
| | Patient Care Bundles | 1 | 2017 | 30 | 0.490 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 169 | 0.460 |
Why?
| | Caregivers | 5 | 2022 | 1080 | 0.460 |
Why?
| | Activities of Daily Living | 4 | 2020 | 442 | 0.460 |
Why?
| | Continuity of Patient Care | 3 | 2026 | 298 | 0.460 |
Why?
| | Laryngoscopy | 1 | 2017 | 122 | 0.460 |
Why?
| | Length of Stay | 11 | 2021 | 1358 | 0.450 |
Why?
| | Survival Rate | 7 | 2021 | 2092 | 0.450 |
Why?
| | Hypoxia | 5 | 2026 | 1211 | 0.450 |
Why?
| | Oxygen | 5 | 2026 | 997 | 0.440 |
Why?
| | Natural Language Processing | 1 | 2016 | 103 | 0.440 |
Why?
| | Adult | 39 | 2024 | 41087 | 0.430 |
Why?
| | Cohort Studies | 20 | 2018 | 6077 | 0.410 |
Why?
| | Documentation | 1 | 2016 | 202 | 0.410 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2020 | 892 | 0.410 |
Why?
| | Resilience, Psychological | 1 | 2016 | 141 | 0.410 |
Why?
| | Hospice Care | 1 | 2017 | 230 | 0.390 |
Why?
| | Neuropsychological Tests | 3 | 2018 | 1149 | 0.390 |
Why?
| | Comorbidity | 5 | 2020 | 1665 | 0.380 |
Why?
| | Risk Factors | 14 | 2020 | 10921 | 0.380 |
Why?
| | Severity of Illness Index | 5 | 2020 | 2921 | 0.380 |
Why?
| | Cognition | 3 | 2024 | 1292 | 0.360 |
Why?
| | Logistic Models | 10 | 2017 | 2126 | 0.360 |
Why?
| | Syndrome | 3 | 2018 | 380 | 0.350 |
Why?
| | Multiple Organ Failure | 2 | 2010 | 122 | 0.350 |
Why?
| | Resuscitation | 4 | 2017 | 314 | 0.350 |
Why?
| | Tidal Volume | 4 | 2026 | 108 | 0.350 |
Why?
| | Neoplasms | 3 | 2023 | 2954 | 0.340 |
Why?
| | Sensorimotor Cortex | 2 | 2021 | 8 | 0.340 |
Why?
| | Lung Transplantation | 1 | 2014 | 326 | 0.330 |
Why?
| | Proteoglycans | 1 | 2011 | 111 | 0.330 |
Why?
| | Aged, 80 and over | 14 | 2020 | 8391 | 0.330 |
Why?
| | Risk Assessment | 9 | 2020 | 3712 | 0.320 |
Why?
| | Cross Infection | 1 | 2013 | 258 | 0.320 |
Why?
| | United States | 18 | 2025 | 16136 | 0.320 |
Why?
| | Physicians | 1 | 2019 | 955 | 0.320 |
Why?
| | Guideline Adherence | 3 | 2017 | 594 | 0.310 |
Why?
| | Multivariate Analysis | 7 | 2020 | 1543 | 0.310 |
Why?
| | Anti-Bacterial Agents | 4 | 2017 | 1942 | 0.310 |
Why?
| | Age Factors | 6 | 2020 | 3347 | 0.290 |
Why?
| | Lactates | 1 | 2009 | 82 | 0.290 |
Why?
| | Biomedical Research | 2 | 2025 | 729 | 0.280 |
Why?
| | Respiratory Insufficiency | 4 | 2022 | 330 | 0.280 |
Why?
| | Neoplasm Proteins | 1 | 2011 | 444 | 0.270 |
Why?
| | Patient Transfer | 2 | 2026 | 224 | 0.270 |
Why?
| | Respiratory Care Units | 1 | 2007 | 2 | 0.270 |
Why?
| | Datasets as Topic | 2 | 2019 | 120 | 0.260 |
Why?
| | Medical Audit | 1 | 2008 | 78 | 0.260 |
Why?
| | Quality Improvement | 3 | 2026 | 1354 | 0.260 |
Why?
| | Oximetry | 2 | 2022 | 124 | 0.260 |
Why?
| | Transitional Care | 2 | 2019 | 46 | 0.260 |
Why?
| | Mood Disorders | 1 | 2009 | 130 | 0.260 |
Why?
| | Neuroimaging | 2 | 2022 | 307 | 0.260 |
Why?
| | Asphyxia | 1 | 2007 | 24 | 0.260 |
Why?
| | Wounds and Injuries | 2 | 2017 | 959 | 0.260 |
Why?
| | Emergency Medical Services | 3 | 2011 | 680 | 0.260 |
Why?
| | Emergencies | 2 | 2010 | 177 | 0.260 |
Why?
| | Stress, Psychological | 1 | 2016 | 1171 | 0.260 |
Why?
| | Betacoronavirus | 2 | 2020 | 288 | 0.250 |
Why?
| | Prospective Studies | 11 | 2021 | 8123 | 0.250 |
Why?
| | Cause of Death | 1 | 2009 | 456 | 0.250 |
Why?
| | Positive-Pressure Respiration | 1 | 2007 | 115 | 0.240 |
Why?
| | Prevalence | 3 | 2025 | 2861 | 0.240 |
Why?
| | Water | 2 | 2020 | 451 | 0.240 |
Why?
| | Triage | 2 | 2020 | 243 | 0.240 |
Why?
| | Program Development | 2 | 2021 | 371 | 0.230 |
Why?
| | Hyperoxia | 2 | 2026 | 126 | 0.230 |
Why?
| | Philadelphia | 3 | 2020 | 55 | 0.230 |
Why?
| | Incidence | 5 | 2018 | 2936 | 0.230 |
Why?
| | Time Factors | 9 | 2019 | 7109 | 0.230 |
Why?
| | Databases, Factual | 3 | 2021 | 1493 | 0.220 |
Why?
| | Medicare | 4 | 2020 | 920 | 0.220 |
Why?
| | Biomarkers | 8 | 2020 | 4340 | 0.220 |
Why?
| | Patient-Centered Care | 1 | 2010 | 553 | 0.210 |
Why?
| | Practice Patterns, Physicians' | 3 | 2010 | 1408 | 0.210 |
Why?
| | Ambulatory Care | 2 | 2026 | 628 | 0.200 |
Why?
| | Quality Indicators, Health Care | 1 | 2026 | 343 | 0.190 |
Why?
| | Neutropenia | 2 | 2016 | 153 | 0.190 |
Why?
| | Patient Admission | 3 | 2016 | 216 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 4 | 2022 | 3926 | 0.180 |
Why?
| | Tics | 1 | 2021 | 6 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2026 | 1763 | 0.180 |
Why?
| | Follow-Up Studies | 8 | 2021 | 5439 | 0.180 |
Why?
| | Tic Disorders | 1 | 2021 | 10 | 0.180 |
Why?
| | Treatment Outcome | 10 | 2022 | 11821 | 0.180 |
Why?
| | Gyrus Cinguli | 1 | 2022 | 98 | 0.170 |
Why?
| | Tourette Syndrome | 1 | 2021 | 28 | 0.170 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2016 | 334 | 0.170 |
Why?
| | Fever | 2 | 2015 | 322 | 0.170 |
Why?
| | Thiamine | 1 | 2021 | 19 | 0.170 |
Why?
| | Motor Cortex | 1 | 2021 | 66 | 0.170 |
Why?
| | Attitude of Health Personnel | 3 | 2019 | 1219 | 0.160 |
Why?
| | Altruism | 1 | 2021 | 28 | 0.160 |
Why?
| | Prognosis | 5 | 2020 | 4351 | 0.160 |
Why?
| | New York City | 1 | 2020 | 89 | 0.160 |
Why?
| | Malaria, Cerebral | 1 | 2020 | 5 | 0.160 |
Why?
| | Databases as Topic | 1 | 2020 | 70 | 0.160 |
Why?
| | Young Adult | 8 | 2021 | 14330 | 0.160 |
Why?
| | Attitude to Health | 2 | 2021 | 421 | 0.150 |
Why?
| | Hospitals | 2 | 2021 | 738 | 0.150 |
Why?
| | Ascorbic Acid | 1 | 2021 | 183 | 0.150 |
Why?
| | Shock | 1 | 2021 | 101 | 0.150 |
Why?
| | Corpus Striatum | 1 | 2021 | 181 | 0.150 |
Why?
| | Return to Work | 1 | 2019 | 21 | 0.150 |
Why?
| | Self-Help Groups | 1 | 2019 | 33 | 0.150 |
Why?
| | Hospitals, University | 4 | 2020 | 178 | 0.150 |
Why?
| | Home Health Nursing | 1 | 2019 | 13 | 0.150 |
Why?
| | Multimodal Imaging | 1 | 2020 | 137 | 0.150 |
Why?
| | Cerebrovascular Circulation | 1 | 2022 | 293 | 0.150 |
Why?
| | Delphi Technique | 1 | 2021 | 350 | 0.150 |
Why?
| | Receptors, GABA-A | 1 | 2020 | 138 | 0.150 |
Why?
| | Intracranial Hemorrhages | 1 | 2020 | 106 | 0.150 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2020 | 152 | 0.150 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2020 | 82 | 0.150 |
Why?
| | Consensus | 1 | 2021 | 467 | 0.150 |
Why?
| | Commerce | 1 | 2020 | 80 | 0.140 |
Why?
| | Benchmarking | 1 | 2020 | 193 | 0.140 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2019 | 80 | 0.140 |
Why?
| | Clinical Protocols | 4 | 2019 | 282 | 0.140 |
Why?
| | Hospital Departments | 1 | 2018 | 9 | 0.140 |
Why?
| | Epidemics | 1 | 2020 | 97 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 733 | 0.140 |
Why?
| | Disaster Planning | 1 | 2020 | 111 | 0.140 |
Why?
| | Teaching Rounds | 1 | 2019 | 74 | 0.140 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 12 | 0.140 |
Why?
| | Predictive Value of Tests | 6 | 2020 | 2113 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2021 | 450 | 0.130 |
Why?
| | Social Determinants of Health | 1 | 2022 | 317 | 0.130 |
Why?
| | Regression Analysis | 3 | 2016 | 999 | 0.130 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 71 | 0.130 |
Why?
| | Ganciclovir | 1 | 2017 | 51 | 0.130 |
Why?
| | Likelihood Functions | 1 | 2017 | 138 | 0.130 |
Why?
| | Sensory Thresholds | 1 | 2017 | 32 | 0.130 |
Why?
| | Touch Perception | 1 | 2017 | 17 | 0.130 |
Why?
| | Reference Values | 1 | 2019 | 796 | 0.130 |
Why?
| | Life Support Systems | 1 | 2017 | 4 | 0.130 |
Why?
| | Mortality | 1 | 2020 | 375 | 0.130 |
Why?
| | Learning | 1 | 2021 | 446 | 0.130 |
Why?
| | Qualitative Research | 5 | 2026 | 1734 | 0.130 |
Why?
| | Disability Evaluation | 1 | 2018 | 297 | 0.120 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1331 | 0.120 |
Why?
| | Artifacts | 1 | 2017 | 143 | 0.120 |
Why?
| | Transportation of Patients | 1 | 2017 | 62 | 0.120 |
Why?
| | Phantoms, Imaging | 1 | 2017 | 160 | 0.120 |
Why?
| | Crowding | 1 | 2017 | 37 | 0.120 |
Why?
| | Workload | 1 | 2018 | 170 | 0.120 |
Why?
| | Medical Staff, Hospital | 1 | 2017 | 80 | 0.120 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2016 | 28 | 0.120 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 26 | 0.120 |
Why?
| | Ventricular Fibrillation | 1 | 2016 | 63 | 0.120 |
Why?
| | Cytomegalovirus | 1 | 2017 | 172 | 0.120 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 330 | 0.120 |
Why?
| | Polyneuropathies | 1 | 2016 | 57 | 0.120 |
Why?
| | Registries | 3 | 2016 | 2400 | 0.120 |
Why?
| | Interleukin-6 | 2 | 2017 | 784 | 0.120 |
Why?
| | Muscular Diseases | 1 | 2016 | 110 | 0.120 |
Why?
| | Nervous System | 1 | 2016 | 68 | 0.120 |
Why?
| | Muscle Weakness | 1 | 2016 | 93 | 0.120 |
Why?
| | Immune System | 1 | 2017 | 181 | 0.120 |
Why?
| | Morbidity | 1 | 2017 | 319 | 0.110 |
Why?
| | Respiratory System | 1 | 2017 | 150 | 0.110 |
Why?
| | Health Personnel | 1 | 2022 | 754 | 0.110 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2017 | 204 | 0.110 |
Why?
| | Hippocampus | 1 | 2021 | 989 | 0.110 |
Why?
| | Medical Informatics | 1 | 2016 | 102 | 0.110 |
Why?
| | Erythrocyte Indices | 1 | 2015 | 33 | 0.110 |
Why?
| | Body Mass Index | 2 | 2015 | 2458 | 0.110 |
Why?
| | Cytomegalovirus Infections | 1 | 2017 | 206 | 0.110 |
Why?
| | Iatrogenic Disease | 1 | 2016 | 74 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2022 | 3416 | 0.110 |
Why?
| | Medical Order Entry Systems | 1 | 2015 | 40 | 0.110 |
Why?
| | California | 1 | 2017 | 475 | 0.110 |
Why?
| | Sex Factors | 2 | 2013 | 2107 | 0.110 |
Why?
| | Adaptation, Psychological | 2 | 2021 | 721 | 0.110 |
Why?
| | Nursing Staff, Hospital | 1 | 2017 | 146 | 0.110 |
Why?
| | Lipids | 1 | 2020 | 714 | 0.110 |
Why?
| | Insurance Claim Review | 1 | 2015 | 87 | 0.110 |
Why?
| | Anticoagulants | 1 | 2020 | 746 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2019 | 706 | 0.110 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 179 | 0.110 |
Why?
| | Hospitals, Low-Volume | 1 | 2014 | 26 | 0.110 |
Why?
| | Thinness | 1 | 2015 | 100 | 0.100 |
Why?
| | Research Design | 2 | 2026 | 1143 | 0.100 |
Why?
| | Patient Care | 1 | 2015 | 120 | 0.100 |
Why?
| | Time-to-Treatment | 1 | 2017 | 257 | 0.100 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 51 | 0.100 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2016 | 522 | 0.100 |
Why?
| | Medical Records Systems, Computerized | 1 | 2014 | 95 | 0.100 |
Why?
| | Drug Administration Schedule | 1 | 2016 | 790 | 0.100 |
Why?
| | Computer Simulation | 1 | 2017 | 1014 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 778 | 0.100 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 422 | 0.090 |
Why?
| | Anxiety | 1 | 2020 | 1125 | 0.090 |
Why?
| | Patient Care Planning | 1 | 2014 | 170 | 0.090 |
Why?
| | Hemoglobins | 1 | 2015 | 384 | 0.090 |
Why?
| | Monitoring, Physiologic | 1 | 2014 | 279 | 0.090 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 96 | 0.090 |
Why?
| | Body Temperature | 1 | 2013 | 228 | 0.090 |
Why?
| | Recovery of Function | 3 | 2025 | 725 | 0.090 |
Why?
| | Self Report | 1 | 2016 | 870 | 0.090 |
Why?
| | Hemodynamics | 1 | 2017 | 1114 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1148 | 0.080 |
Why?
| | Antiviral Agents | 1 | 2017 | 779 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2015 | 287 | 0.080 |
Why?
| | Asthma | 1 | 2022 | 1800 | 0.080 |
Why?
| | Calibration | 1 | 2011 | 154 | 0.080 |
Why?
| | Electronic Health Records | 3 | 2026 | 1210 | 0.080 |
Why?
| | Reference Standards | 1 | 2011 | 176 | 0.080 |
Why?
| | Hypoglycemia | 1 | 2015 | 490 | 0.080 |
Why?
| | Pilot Projects | 1 | 2016 | 1888 | 0.080 |
Why?
| | ROC Curve | 3 | 2020 | 617 | 0.080 |
Why?
| | Sleep | 1 | 2018 | 896 | 0.080 |
Why?
| | Temperature | 1 | 2013 | 635 | 0.080 |
Why?
| | Blood Gas Analysis | 1 | 2010 | 80 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2013 | 385 | 0.080 |
Why?
| | Aging | 1 | 2020 | 1996 | 0.070 |
Why?
| | Mental Health | 1 | 2016 | 779 | 0.070 |
Why?
| | Adolescent | 4 | 2022 | 22557 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2017 | 3017 | 0.070 |
Why?
| | Infusions, Intravenous | 1 | 2010 | 432 | 0.070 |
Why?
| | Anxiety Disorders | 1 | 2012 | 354 | 0.070 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2010 | 162 | 0.070 |
Why?
| | Hospitalists | 1 | 2013 | 288 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2017 | 3647 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1998 | 0.070 |
Why?
| | Probability | 1 | 2009 | 309 | 0.070 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 426 | 0.070 |
Why?
| | Telemedicine | 1 | 2017 | 966 | 0.070 |
Why?
| | Hematologic Neoplasms | 1 | 2010 | 170 | 0.070 |
Why?
| | International Classification of Diseases | 2 | 2022 | 142 | 0.070 |
Why?
| | Depression | 2 | 2019 | 1575 | 0.060 |
Why?
| | Child | 3 | 2021 | 22693 | 0.060 |
Why?
| | Survival Analysis | 1 | 2009 | 1378 | 0.060 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2026 | 135 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1591 | 0.050 |
Why?
| | Models, Statistical | 2 | 2020 | 669 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2026 | 417 | 0.050 |
Why?
| | Influenza, Human | 1 | 2010 | 640 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 5899 | 0.050 |
Why?
| | Informatics | 1 | 2022 | 6 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2016 | 517 | 0.050 |
Why?
| | Glutamates | 1 | 2022 | 66 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2022 | 20 | 0.040 |
Why?
| | Patient Safety | 1 | 2026 | 352 | 0.040 |
Why?
| | Technology | 1 | 2022 | 100 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 907 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2012 | 329 | 0.040 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2020 | 69 | 0.040 |
Why?
| | Australia | 1 | 2021 | 291 | 0.040 |
Why?
| | United Kingdom | 1 | 2021 | 377 | 0.040 |
Why?
| | Rehabilitation Centers | 1 | 2020 | 39 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2021 | 255 | 0.040 |
Why?
| | Odds Ratio | 2 | 2014 | 1077 | 0.040 |
Why?
| | Internationality | 1 | 2019 | 156 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2020 | 343 | 0.040 |
Why?
| | Feedback | 1 | 2019 | 183 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2020 | 152 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2017 | 78 | 0.030 |
Why?
| | Touch | 1 | 2017 | 38 | 0.030 |
Why?
| | Linear Models | 1 | 2020 | 857 | 0.030 |
Why?
| | Michigan | 1 | 2017 | 203 | 0.030 |
Why?
| | Software | 1 | 2022 | 676 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1053 | 0.030 |
Why?
| | Virus Activation | 1 | 2017 | 97 | 0.030 |
Why?
| | Hospital Units | 1 | 2016 | 32 | 0.030 |
Why?
| | Geriatric Assessment | 1 | 2018 | 244 | 0.030 |
Why?
| | Partial Pressure | 1 | 2016 | 30 | 0.030 |
Why?
| | Angiopoietin-2 | 1 | 2016 | 15 | 0.030 |
Why?
| | Telemetry | 1 | 2016 | 41 | 0.030 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2016 | 90 | 0.030 |
Why?
| | Neural Inhibition | 1 | 2017 | 186 | 0.030 |
Why?
| | Blood Urea Nitrogen | 1 | 2015 | 53 | 0.030 |
Why?
| | International Normalized Ratio | 1 | 2015 | 55 | 0.030 |
Why?
| | Fluid Therapy | 1 | 2017 | 154 | 0.030 |
Why?
| | Perception | 1 | 2018 | 373 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2016 | 211 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2016 | 211 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 220 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2016 | 268 | 0.030 |
Why?
| | Resuscitation Orders | 1 | 2015 | 48 | 0.030 |
Why?
| | Early Medical Intervention | 1 | 2015 | 59 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 1038 | 0.030 |
Why?
| | Urinary Tract Infections | 1 | 2017 | 209 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 930 | 0.030 |
Why?
| | Internet | 1 | 2019 | 660 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 6073 | 0.030 |
Why?
| | Vasoconstrictor Agents | 1 | 2015 | 148 | 0.030 |
Why?
| | Interleukins | 1 | 2016 | 248 | 0.030 |
Why?
| | Hospital Rapid Response Team | 1 | 2014 | 20 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 196 | 0.030 |
Why?
| | Poisson Distribution | 1 | 2014 | 77 | 0.030 |
Why?
| | Health Services Research | 1 | 2017 | 390 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1133 | 0.030 |
Why?
| | Rewarming | 1 | 2013 | 22 | 0.020 |
Why?
| | Blood Coagulation Disorders | 1 | 2015 | 190 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 568 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2017 | 2070 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2014 | 368 | 0.020 |
Why?
| | Medical Records | 1 | 2013 | 193 | 0.020 |
Why?
| | Age Distribution | 1 | 2012 | 399 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 382 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1107 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 970 | 0.020 |
Why?
| | Selection Bias | 1 | 2010 | 38 | 0.020 |
Why?
| | Area Under Curve | 1 | 2010 | 335 | 0.020 |
Why?
| | Hospitals, Teaching | 1 | 2010 | 121 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2010 | 140 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 321 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2010 | 313 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2016 | 866 | 0.020 |
Why?
| | Lung | 1 | 2021 | 4122 | 0.020 |
Why?
| | Creatinine | 1 | 2010 | 511 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10114 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2010 | 422 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11913 | 0.010 |
Why?
| | Blood Glucose | 1 | 2015 | 2360 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2867 | 0.010 |
Why?
| | Animals | 1 | 2018 | 38106 | 0.010 |
Why?
|
|
Mikkelsen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|